Finance

Lists
AYTU:NASDAQ
Aytu Biopharma Inc
2,02 $
-1,22%
(-0,025) 1D
1,99 $
-1,91% (-0,039)
After hours
Closed: 9 қаз., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AYTU...
Open
2,04 $
High
2,07 $
Low
2,02 $
Mkt. cap
22,01 млн
Avg. vol.
41,63 мың
Volume
10,53 мың
52-wk high
3,06 $
52-wk low
1,80 $
EPS
-1,16 $
Beta
0,17
Shares outstanding
10,87 млн
No. of employees
76
Open
2,04 $
High
2,07 $
Low
2,02 $
Mkt. cap
22,01 млн
Avg. vol.
41,63 мың
Volume
10,53 мың
52-wk high
3,06 $
52-wk low
1,80 $
EPS
-1,16 $
Beta
0,17
Shares outstanding
10,87 млн
No. of employees
76
News stories
From web sources and news partners
About Aytu Biopharma Inc
CEO-
Employees76
Founded2002
HeadquartersДенвер, Колорадо, Америка Құрама Штаттары
SectorPharmaceutical industry
Websiteaytubio.com
Analyst ratings
Based on 3 analysts giving stock ratings to AYTU in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AYTU in the last 3 months.
Highest
Current 2,02 $
15,00 $ (+640,74%)
Average
9,67 $ (+377,53%)
Lowest
7,00 $ (+245,68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
15,00 $
+640,7%
09/29/2026
Naz Rahman
Maxim Group
Buy
Reiterated
7,00 $
+245,7%
09/24/2026
Thomas Flaten
Lake Street
Buy
Maintained
7,00 $
+245,7%
09/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
13,89 млн
15,16 млн
12,41 млн
16,11 млн
Cost of goods sold
4,70 млн
5,54 млн
4,81 млн
5,70 млн
Cost of revenue
4,70 млн
5,54 млн
4,81 млн
5,70 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,25 млн
11,07 млн
10,90 млн
10,42 млн
Operating expense
10,69 млн
11,59 млн
11,66 млн
11,19 млн
Total operating expenses
15,39 млн
17,14 млн
16,48 млн
16,88 млн
Operating income
-1,50 млн
-1,97 млн
-4,06 млн
-777,00 м.
Other non operating income
3,98 млн
-8,05 млн
-1,11 млн
1,16 млн
EBT including unusual items
1,96 млн
-10,58 млн
-5,61 млн
-4,00 мың
EBT excluding unusual items
1,96 млн
-10,58 млн
-5,61 млн
-4,00 мың
Income tax expense
-
-
10,00 мың
11,00 мың
Effective tax rate
-
-
-0,18%
-275,00%
Other operating expenses
-
-
-
-
Net income
1,96 млн
-10,58 млн
-5,62 млн
-15,00 мың
Net profit margin
14,15%
-69,79%
-45,27%
-0,09%
Earnings per share
-0,09
-0,23
-0,41
-0,06
Interest and investment income
-
-
-
-
Interest expense
-516,00 м.
-560,00 м.
-436,00 м.
-383,00 м.
Net interest expenses
-516,00 м.
-560,00 м.
-436,00 м.
-383,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-701,00 м.
-1,08 млн
-2,94 млн
344,00 м.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары